- Home
- CRDL vs PRPL Comparison
CRDL vs PRPL Comparison
Compare CRDL & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- PRPL
- Stock Information
- Founded
- CRDL 2017
- PRPL 2010
- Country
- CRDL Canada
- PRPL United States
- Employees
- CRDL N/A
- PRPL N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- PRPL Home Furnishings
- Sector
- CRDL Health Care
- PRPL Consumer Discretionary
- Exchange
- CRDL Nasdaq
- PRPL Nasdaq
- Market Cap
- CRDL 102.0M
- PRPL 90.3M
- IPO Year
- CRDL N/A
- PRPL N/A
- Fundamental
- Price
- CRDL $1.20
- PRPL $0.93
- Analyst Decision
- CRDL Strong Buy
- PRPL Buy
- Analyst Count
- CRDL 3
- PRPL 3
- Target Price
- CRDL $9.00
- PRPL $1.70
- AVG Volume (30 Days)
- CRDL 274.8K
- PRPL 485.8K
- Earning Date
- CRDL 03-31-2025
- PRPL 03-11-2025
- Dividend Yield
- CRDL N/A
- PRPL N/A
- EPS Growth
- CRDL N/A
- PRPL N/A
- EPS
- CRDL N/A
- PRPL N/A
- Revenue
- CRDL N/A
- PRPL $504,838,000.00
- Revenue This Year
- CRDL N/A
- PRPL N/A
- Revenue Next Year
- CRDL N/A
- PRPL $1.83
- P/E Ratio
- CRDL N/A
- PRPL N/A
- Revenue Growth
- CRDL N/A
- PRPL N/A
- 52 Week Low
- CRDL $1.15
- PRPL $0.75
- 52 Week High
- CRDL $3.12
- PRPL $2.33
- Technical
- Relative Strength Index (RSI)
- CRDL 41.60
- PRPL 39.91
- Support Level
- CRDL $1.15
- PRPL $0.99
- Resistance Level
- CRDL $1.51
- PRPL $1.09
- Average True Range (ATR)
- CRDL 0.10
- PRPL 0.07
- MACD
- CRDL -0.01
- PRPL -0.02
- Stochastic Oscillator
- CRDL 13.65
- PRPL 0.00
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.